A.I. Virtanen Institute for Molecular Sciences - News

The findings of the doctoral research may help develop new gene therapy and regenerative medicine approaches for ischemic heart disease and heart failure.

The purpose of AtheroPortal is to facilitate researchers’ access to data on atherosclerosis, and thereby accelerate the identification of new disease mechanisms, biomarkers, and potential drug development targets.

Leading international experts present the latest research and envisage the future at the Kuopio Neuroscience 50 Years symposium on 15–17 June 2026.

“I don’t think many programmes give you this kind of exposure to both academia and business,” said doctoral researcher Ahmed Mohamed at the kick-out event of the Neuro-Innovation doctoral programme.

Lithium chloride may affect many cellular level changes in Alzheimer’s disease, a new study from the University of Eastern Finland shows.

A total of 24 professors will give inaugural lectures on the key themes of their research.

The PhD study focused on the interaction of the brain's own immune cells, microglia, with amyloid plaques in Alzheimer's disease.

While modern cancer treatments have reduced cancer deaths, they often have adverse effects on the cardiovascular system. “Among breast cancer survivors, cardiovascular disease is actually the number one cause of death now,” says Professor Andreas Beyer.

The University of Eastern Finland opened fall 2025 an internal call for Proof of Concept (PoC) funding to accelerate the commercialization of ideas emerging from research.

The University of Eastern Finland’s new podcast series opens the curtains on research and innovation activities. The opening episode explores how to combine a career as a top researcher and an innovator.